BioCryst Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 413
EBIT TTM (mln): -29
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 2 3 11 2 2 0 0 6 71 57 75 64 20 26 17 14 48 26 25 21 49 18 157 271 331 451
Przychód Δ r/r 0.0% 32.6% 236.5% -84.1% -7.9% -79.4% -54.9% 3990.4% 1046.8% -20.6% 31.9% -14.9% -69.1% 33.9% -34.1% -21.5% 254.6% -45.4% -4.4% -18.0% 136.5% -63.5% 782.4% 72.3% 22.4% 36.0%
Marża brutto 120.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 93.9% 99.9% 100.0% 99.5% 99.4% 99.1% 96.1% 89.8% 93.2% 97.7% 91.6% 90.6% 95.4% 97.6% 98.1% 97.3%
EBIT (mln) -8 -10 -5 -17 -13 -22 -27 -47 -32 -27 -14 -33 -50 -34 -31 -46 -39 -49 -57 -94 -99 -175 -178 -148 -104 -3
EBIT Δ r/r 0.0% 21.4% -49.3% 232.1% -23.3% 71.3% 24.9% 72.9% -31.3% -15.8% -49.4% 141.9% 49.2% -31.7% -9.4% 49.0% -13.8% 23.2% 18.1% 64.1% 5.6% 75.7% 1.7% -16.5% -30.1% -97.5%
EBIT (%) -324.0% -296.5% -44.7% -932.9% -777.2% -6456.5% -17895.2% -756.3% -45.3% -48.0% -18.4% -52.3% -252.4% -128.9% -177.2% -336.4% -81.7% -184.4% -227.9% -456.2% -203.7% -981.1% -113.1% -54.8% -31.3% -0.6%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 4 5 5 5 5 6 9 9 12 15 59 99 108 99
EBITDA (mln) -9 -9 -4 -15 -12 -21 -26 -46 -31 -26 -14 -33 -46 -32 -31 -46 -39 -48 -56 -92 -98 -165 -178 -143 -102 13
EBITDA(%) -352.0% -276.4% -35.3% -841.6% -709.9% -6166.2% -17325.9% -743.1% -43.4% -45.2% -18.4% -52.3% -232.1% -121.4% -176.7% -335.7% -80.6% -181.4% -223.9% -445.3% -199.7% -928.2% -113.0% -52.9% -30.8% 2.8%
Podatek (mln) -3 -11,566 -4,981 0 -12,687 -1 1,077 -26,055 0 -0 -2 501 6 4 4 5 5 6 8 2 11 14 2 3 0 2
Zysk Netto (mln) -5 -12 -5 -17 -13 -21 -26 -44 -29 -25 -13 -33 -57 -39 -30 -45 -43 -55 -66 -101 -120 -197 -184 -247 -227 -89
Zysk netto Δ r/r 0.0% 118.4% -56.9% 239.5% -25.0% 66.2% 23.7% 67.1% -33.4% -14.9% -45.6% 143.3% 74.0% -31.4% -23.0% 50.1% -4.8% 28.2% 19.3% 53.9% 18.6% 63.7% -6.4% 34.3% -8.3% -60.8%
Zysk netto (%) -212.0% -349.2% -44.7% -954.0% -777.2% -6264.2% -17185.3% -702.2% -40.8% -43.7% -18.0% -51.5% -289.9% -148.6% -173.7% -332.1% -89.1% -209.3% -261.2% -490.3% -245.9% -1103.6% -117.1% -91.2% -68.4% -19.7%
EPS -0.34 -0.66 -0.28 -0.96 -0.72 -1.0 -1.01 -1.5 -0.89 -0.65 -0.35 -0.73 -1.26 -0.79 -0.55 -0.68 -0.59 -0.75 -0.78 -0.98 -1.04 -1.18 -1.03 -1.33 -1.18 -0.43
EPS (rozwodnione) -0.34 -0.61 -0.28 -0.96 -0.72 -1.0 -1.01 -1.5 -0.89 -0.65 -0.35 -0.73 -1.26 -0.79 -0.55 -0.68 -0.59 -0.75 -0.78 -0.98 -1.04 -1.18 -1.03 -1.33 -1.18 -0.43
Ilośc akcji (mln) 15 17 18 18 18 21 26 29 33 38 39 45 45 49 55 67 73 74 84 103 116 167 179 186 192 207
Ważona ilośc akcji (mln) 15 19 18 18 18 21 26 29 33 38 39 45 45 49 55 67 73 74 84 103 116 167 179 186 192 207
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD